Drugstore Chain Must Mediate EpiPen Antitrust Claim 1st, MDL Judge Rules

(June 19, 2020, 1:05 PM EDT) -- KANSAS CITY, Kan. — The Kansas federal judge overseeing the EpiPen multidistrict litigation on June 18 said that a Core Distribution Services Agreement required a retail pharmacy chain to mediate its antitrust claim against EpiPen manufacturer Mylan N.V. before it presses an antitrust lawsuit (KPH Healthcare Services, Inc., et al. v. Mylan N.V., et al., No. 20-2065, D. Kan., 2020 U.S. Dist. LEXIS 106808)....

Attached Documents

Related Sections